Latest News
- Researchers create framework for evaluating how fast a cancer will grow
An international team of researchers led by UCLA’s Paul Boutros have created a new way to accurately estimate how fast an individual cancer is evolving using open-source software.
January 10, 2020 6:00 AM
detail - Outrunning cancer
Advances in robotic surgery have helped physicians remove throat tumors without any facial incision and patients can go home within a few days.
December 18, 2019 9:00 AM
detail - Targeted therapy drug helps women with aggressive breast cancer live longer
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.
December 11, 2019 2:00 PM
detail - UCLA study shows inhibition of gene helps overcome resistance to immunotherapy
New study from UCLA scientists helps explain why some people with advanced cancer may not respond to one of the leading immunotherapies, PD-1 blockade, and how a new combination approach may help overcome resistance to the immunotherapy drug.
December 09, 2019 8:00 AM
detail - Cancer researcher receives grant to study how deep learning can improve immunotherapy
Willy Hugo, PhD, has received a $75,000 grant from the Margaret E. Early Medical Research Trust to help understand the underlying mechanism of response to immune checkpoint inhibitors, a type of immunotherapy drug.
December 03, 2019 8:00 AM
detail - Researchers identify protein that governs human blood stem cell self-renewal
UCLA scientists have discovered a link between a protein and the ability of human blood stem cells to self-renew.
November 29, 2019 12:00 PM
detail - Automated technique helps identify cancer cell metabolism inhibitors
UCLA Jonsson Comprehensive Cancer Center researchers have developed a new automated method for testing hundreds of molecules at a time to find out which ones block cancer cells from consuming glucose — the sugars they need to spread and grow.
November 29, 2019 8:00 AM
detail - A pep talk for pancreatic cancer
In this video, meet UCLA Jonsson Comprehensive Cancer Center researchers Drs. Randy Hecht, David Dawson, Zev Wainberg and Timothy Donahue, who are working on new ways to treat this tough disease, and offer new hope for the future because of breakthroughs in research and patient care.
November 26, 2019 8:00 AM
detail - Dozens of UCLA scientists rank among world’s most-cited researchers
Three UCLA researchers have received awards totaling more than $18 million from the California Institute for Regenerative Medicine, the state’s stem cell agency.
November 21, 2019 9:00 AM
detail - Grant awarded to develop new imaging techniques that target tumor environment
Dr. Jeremie Calais has been awarded $105,000 from the Society of Nuclear Medicine and Molecular Imaging. The two-year grant will help fund a new UCLA-led study that aims to advance the method of locating cancer by detecting tumor stroma.
November 18, 2019 10:00 AM
detail - New screening method identifies inhibitors of cancer cell metabolism
A new screening system leverages redundancy in an important component of a cell to help identify new drugs that specifically and potently block processes that are essential for cancer cell growth.
November 18, 2019 8:00 AM
detail - Three UCLA scientists receive grants totaling more than $18 million
Three UCLA researchers have received awards totaling more than $18 million from the California Institute for Regenerative Medicine, the state’s stem cell agency.
November 01, 2019 8:00 AM
detail - National Cancer Institute awards UCLA prostate cancer program an $8.7 million grant
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.
October 31, 2019 10:00 AM
detail - Mitochondria’s activity in tumors could predict response to lung cancer drug
Researchers at the UCLA Jonsson Comprehensive Cancer Center and David Geffen School of Medicine at UCLA have identified a new biomarker that could indicate how likely someone is to respond to treatment for lung cancer.
October 30, 2019 11:00 AM
detail - Lung cancer patients with depression likely to receive radiotherapy over surgery
Researchers from the UCLA Jonsson Comprehensive Cancer Center and the Dana-Farber Cancer Institute analyzed 515 patients with early stage non-small-cell lung cancer who were age 65 and older.
October 29, 2019 2:30 PM
detail - Two early career researchers honored by Prostate Cancer Foundation
The Prostate Cancer Foundation has honored two UCLA researchers, Dr. Amar Kishan and Dr. Jeremy Shelton, with PCF Young Investigator awards as part of their 2019 class.
October 29, 2019 8:00 AM
detail - Two UCLA doctors named to National Academy of Medicine
Two UCLA professors, Dr. Denise Aberle and Dr. Carol Mangione, have been elected to the National Academy of Medicine, one of the highest honors in health and medicine.
October 21, 2019 9:00 AM
detail